Skip to main content
Single Use Control System in Pharmaceutical manufacturing plant
12/10/2026

Standardising Single-Use Systems

Achieving an 89% reduction in contamination risk

At ISPE's Annual Meeting in Washington, DC, PM Group and a key multi-national Life Sciences client shared a practical case study on how risk-based design and standardization can strengthen reliability in biologics manufacturing.

As multi-product facilities increasingly adopt single-use systems to support flexibility, rapid changeovers, and scalability, ensuring sterility and operational consistency remains a key challenge. Manual interventions and non-standardized designs can introduce variability, increase contamination risk, and impact supply reliability.

During their session, PM Group's Tim Lash, Voke Dortie and a Single-Use specialist from our client's team presented a risk-based approach developed and implemented in a live commercial facility. Using a quasi-quantitative risk-scoring framework, the team evaluated sterile boundary risks and compared existing configurations with a standardized modular design. 

"This approach reduced system complexity, minimized interventions, and delivered an estimated 69% reduction in contamination risk," said Tim.  "The resulting design can be scaled across multiple products and implemented with minimal operational disruption, helping create more resilient, efficient, and reliable manufacturing systems".


More about our expertise in Single-Use and other specialist pharma manufacturing areas.